PRODUCT NAME:

Product Name: Voriconazole CLIA Kit (Chemiluminescence Immunoassay) Abbreviation: Vorl 

INTENDED USE:

Voriconazole CLIA Kit (Chemiluminescence Immunoassay) is an in vitro diagnostic test for the quantitative detection of Voriconazole (Vorl) in human serum and plasma specimen. This product is intended to be used by laboratory professional workers only. This kit is used for auxiliary diagnosis. Results must be combined with clinical observations, patient history, other laboratory parameters, and epidemiological information. Voriconazole is a triazole antifungal drug with broad antibacterial spectrum and high oral bioavailability. It mainly has bactericidal effect on Aspergillus, and has good antibacterial effect on Candida, including Candida krusei and Candida glabrata which are resistant to fluconazole, and also has antibacterial activity against Sedora and Fusarium. The pharmacokinetics of voriconazole vary greatly among individuals, and its blood concentration is significantly related to clinical efficacy and adverse reactions such as abnormal liver function, visual changes, or visual disturbances. Therefore, the monitoring of voriconazole blood concentration is of great significance for clinical rational drug use and avoiding or reducing adverse reactions.